EQUITY RESEARCH MEMO

OXOS Medical

Generated 5/9/2026

Executive Summary

Conviction (model self-assessment)65/100

OXOS Medical is a US-based medical device company founded in 2016 that specializes in developing portable, low-radiation X-ray systems. Its flagship product, the Micro C-arm, delivers diagnostic-quality imaging at the point of care, significantly reducing radiation exposure compared to traditional systems. The company's technology addresses key challenges in medical imaging: accessibility, efficiency, and safety. By enabling radiographic diagnostics in diverse clinical settings—from emergency departments to rural clinics—OXOS aims to democratize medical imaging. With a strong intellectual property portfolio and growing commercial traction, the company is positioned to disrupt the traditional radiology market. OXOS has secured partnerships with healthcare providers and distributors, and its devices have received FDA clearance for multiple indications. The company continues to expand its product line and clinical applications, targeting both domestic and international markets. OXOS Medical represents a compelling opportunity in the medical device space, with a clear value proposition and a scalable business model.

Upcoming Catalysts (preview)

  • Q3 2026FDA 510(k) clearance for next-generation Micro C-arm with enhanced imaging capabilities80% success
  • Q2 2026Strategic partnership with a major hospital network for deployment of portable X-ray systems60% success
  • Q4 2026Series C funding round to support commercialization and international expansion50% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)